DP
APLT

DSAM Partners’s Applied Therapeutics APLT Stock Holding History

DSAM Partners’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-67,125
Closed -$1.4M – 22
2021
Q2 		$1.4M Hold
67,125
– – 0.23% 42
2021
Q1 		$1.26M Buy
+67,125
New +$1.45M 0.23% 45

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

DSAM Partners's APLT Position: Q3 2021 in Review

DSAM Partners sold out of Applied Therapeutics (APLT) in Q3 2021, closing a stake of 67,125 shares — an estimated $1.4M sold.

DSAM Partners first reported a position in APLT in Q1 2021 and held it in 2 quarters. The position peaked at $1.4M in Q2 2021. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2021.

  • DSAM Partners reported no remaining Applied Therapeutics position as of Q3 2021 after selling out during the quarter.
  • DSAM Partners sold 67,125 Applied Therapeutics shares in Q3 2021, an estimated $1.4M.
  • DSAM Partners first reported a position in Applied Therapeutics in Q1 2021 and held it in 2 quarters.
  • DSAM Partners's Applied Therapeutics position peaked at $1.4M in Q2 2021.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2021.

Based on DSAM Partners's 13F filing for Q3 2021, filed 15 Nov 2021.